Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Ovarian Cancer Metastatic × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 95 Uterine Cervical Neoplasms 51 Endometrial Neoplasms 32 Fallopian Tube Neoplasms 29 Carcinoma, Ovarian Epithelial 26 Breast Neoplasms 22 Neoplasms 13 Pancreatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Uterine Cervical Dysplasia 11 Recurrence 10 Stomach Neoplasms 9 Colorectal Neoplasms 9 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 7 Sarcoma 7 Urinary Bladder Neoplasms 6 Lung Neoplasms 6 Vulvar Neoplasms 5 Vaginal Neoplasms 5 Testicular Neoplasms 5 Esophageal Neoplasms 5 Uterine Neoplasms 4 Rectal Neoplasms 4 Peritoneal Neoplasms 4 Melanoma 4 Lymphoma, Non-Hodgkin 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Sezary Syndrome 3

Interventions

fludarabine 1 aldesleukin 1 Interleukin-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389229 2020-12-16

OVSTAR

Immetacyte Ltd

Phase 1/2 Withdrawn

Ovarian Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡